Shenkman Capital Management Inc has filed its 13F form on August 11, 2025 for Q2 2025 where it was disclosed a total value porftolio of $118 Million distributed in 124 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Invesco ETF Tr Ii Sr Ln ETF with a value of $78.2M, Spdr Bloomberg Short Term High with a value of $15.3M, Ishares Tr Broad Usd High Yiel with a value of $12.9M, Lending Tree, Inc. with a value of $4.26M, and Altice Usa, Inc. with a value of $3.85M.
Examining the 13F form we can see an increase of $16.4M in the current position value, from $102M to 118M .
Shenkman Capital Management Inc is based out at New York, NY
Below you can find more details about Shenkman Capital Management Inc portfolio as well as his latest detailed transactions.
Portfolio value
$118 Million
ETFs: $106 Million
Communication Services: $7.31 Million
Financial Services: $4.26 Million
Stock
Market Cap.
Holding Value (Reported)
# of Shares.
Last Trade
Trade History
-
$0
0.0% of portfolio
-
Q2 2025
Added 157.33%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Added 12.0%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 52.19%
Summit Midstream Corporation
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 53.24%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 17.42%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 72.11%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 6.88%
-
$0
0.0% of portfolio
-
Q2 2025
Added 11.29%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 17.94%
-
$0
0.0% of portfolio
-
Q2 2025
Added 6.8%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 34.23%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 34.61%
-
$0
0.0% of portfolio
-
Q2 2025
Added 101.85%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 10.45%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 91.53%
-
$0
0.0% of portfolio
-
Q2 2025
Added 28.19%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 6.86%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 98.36%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 95.12%
-
$0
0.0% of portfolio
-
Q2 2025
Added 84.13%
-
$0
0.0% of portfolio
-
Q2 2025
Added 0.64%
-
$0
0.0% of portfolio
-
Q2 2025
Added 33.44%
Envista Holdings Corporation
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 60.53%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 84.42%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 96.99%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 56.18%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 45.59%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 65.34%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 40.17%
Alnylam Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 57.1%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 43.97%
-
$0
0.0% of portfolio
-
Q2 2025
Added 78.25%
-
$0
0.0% of portfolio
-
Q2 2025
Added 34.42%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 2.98%
-
$0
0.0% of portfolio
-
Q2 2025
Added 28.37%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 46.09%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 63.63%